Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Mori, Marcelo A ^a   Sales, Vicência Micheline ^a   Motta, Fabiana Louise ^a   Fonseca, Raphael Gomes ^a   Alenina, Natalia ^b   Guadagnini, Dioze ^c   Schadock, Ines ^b   Silva, Elton Dias ^a   Torres, Hugo A M ^a   dos Santos, Edson Lucas ^a   Castro, Charlles Heldan ^a   D'Almeida, Vânia ^a   Andreotti, Sandra ^d   Campaña, Amanda Baron ^d   Sertié, Rogério A L ^d   Saad, Mario J A ^b   Lima, Fabio Bessa ^d   Bader, Michael ^b   Pesquero, João Bosco ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BRADYKININ; BRADYKININ B1 RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; KININ;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FUNCTION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE MUTANT;

MUS;

ADIPOCYTES; ANIMALS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; KININS; MALE; MICE; MICE, KNOCKOUT; OBESITY; RECEPTOR, BRADYKININ B1;

EID: 84866371512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044782     Document Type: Article

References (37)

1. Arner P, (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14: 137-145.
2. Tilg H, Moschen AR, (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783.
3. Waki H, Tontonoz P, (2007) Endocrine functions of adipose tissue. Annu Rev Pathol 2: 31-56.
4. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
5. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819.
6. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL, (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57: 27-77.
7. Bhoola KD, Figueroa CD, Worthy K, (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80.
8. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, et al. (2004) Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143: 803-818.
9. Dietze G, Wicklmayr M, (1977) [Effect of bradykinin on muscular glucose uptake in man (author's transl)]. Klin Wochenschr 55: 357-358.
10. Dietze GJ, Wicklmayr M, Rett K, Jacob S, Henriksen EJ, (1996) Potential role of bradykinin in forearm muscle metabolism in humans. Diabetes 45Suppl 1: S110-114.
11. Miyata T, Taguchi T, Uehara M, Isami S, Kishikawa H, et al. (1998) Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur J Endocrinol 138: 344-352.
12. Isami S, Kishikawa H, Araki E, Uehara M, Kaneko K, et al. (1996) Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway. Diabetologia 39: 412-420.
13. Beard KM, Lu H, Ho K, Fantus IG, (2006) Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 55: 2678-2687.
14. Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I, et al. (2001) Role of the B(2) receptor of bradykinin in insulin sensitivity. Hypertension 38: 1355-1360.
15. Zuccollo A, Navarro M, Frontera M, Cueva F, Carattino M, et al. (1999) The involvement of kallikrein-kinin system in diabetes type I (insulitis). Immunopharmacology 45: 69-74.
16. Araujo RC, Mori MA, Merino VF, Bascands JL, Schanstra JP, et al. (2006) Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem 387: 431-436.
17. Mori MA, Araujo RC, Reis FC, Sgai DG, Fonseca RG, et al. (2008) Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 57: 1491-1500.
18. Dias JP, Couture R, (2012) Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance. Diabetes Obes Metab 14: 244-253.
19. Cassis LA, Police SB, Yiannikouris F, Thatcher SE, (2008) Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 10: 93-98.
20. Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, et al. (1998) Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47: 550-558.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
22. Duka A, Kintsurashvili E, Duka I, Ona D, Hopkins TA, et al. (2008) Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension 51: 1352-1357.
23. Merino VF, Todiras M, Mori MA, Sales VM, Fonseca RG, et al. (2009) Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J Mol Med (Berl). 87: 953-963.
24. Prada PO, Hirabara SM, de Souza CT, Schenka AA, Zecchin HG, et al. (2007) L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity. Diabetologia 50: 1949-1959.
25. Shi H, Cave B, Inouye K, Bjorbaek C, Flier JS, (2006) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55: 699-707.
26. Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS, (2002) Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 143: 1502-1511.
27. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25-38.
28. Trayhurn P, Beattie JH, (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339.
29. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, et al. (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 97: 8140-8145.
30. Rodbell M, (1964) Metabolism of Isolated Fat Cells. I. Effects of Hormones on Glucose Metabolism and Lipolysis. J Biol Chem 239: 375-380.
31. McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, et al. (1992) The cytosensor microphysiometer: biological applications of silicon technology. Science 257: 1906-1912.
32. Lima FB, Bao S, Garvey WT, (1994) Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes. Chronic ability to increase glycogen synthase activity. Diabetes 43: 53-62.
33. Alonso-Vale MI, Andreotti S, Mukai PY, Borges-Silva CN, Peres SB, et al. (2008) Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 45: 422-429.
34. DeBlasi A, O'Reilly K, Motulsky HJ, (1989) Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10: 227-229.
35. Bogan JS, McKee AE, Lodish HF, (2001) Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations. Mol Cell Biol 21: 4785-4806.
36. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, et al. (1990) A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci U S A 87: 9590-9594.
37. Mori MA, Liu M, Bezy O, Almind K, Shapiro H, et al. (2010) A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease. Diabetes 59: 2960-2971.